BECAPLERMIN: 2,059 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,059
Total FAERS Reports
69 (3.4%)
Deaths Reported
476
Hospitalizations
2,059
As Primary/Secondary Suspect
2
Life-Threatening
5
Disabilities
Prescription
Status
FDA Application: 103691 ·
First Report: 2001 · Latest Report: 20250414
What Are the Most Common BECAPLERMIN Side Effects?
#1 Most Reported
Off label use
672 reports (32.6%)
#2 Most Reported
Wound complication
448 reports (21.8%)
#3 Most Reported
Application site pain
313 reports (15.2%)
All BECAPLERMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 672 | 32.6% | 29 | 131 |
| Wound complication | 448 | 21.8% | 1 | 75 |
| Application site pain | 313 | 15.2% | 1 | 24 |
| Drug ineffective | 191 | 9.3% | 1 | 34 |
| Inappropriate schedule of drug administration | 169 | 8.2% | 0 | 46 |
| Osteomyelitis | 162 | 7.9% | 2 | 96 |
| Incorrect drug administration duration | 119 | 5.8% | 1 | 19 |
| Wound infection | 114 | 5.5% | 1 | 53 |
| Application site erythema | 102 | 5.0% | 0 | 6 |
| Toe amputation | 102 | 5.0% | 1 | 64 |
| Application site infection | 96 | 4.7% | 0 | 34 |
| Wound secretion | 86 | 4.2% | 0 | 16 |
| Cellulitis | 80 | 3.9% | 1 | 59 |
| Drug ineffective for unapproved indication | 80 | 3.9% | 0 | 11 |
| Application site discolouration | 74 | 3.6% | 0 | 8 |
| Infection | 66 | 3.2% | 1 | 29 |
| Application site haemorrhage | 60 | 2.9% | 0 | 1 |
| Peripheral swelling | 58 | 2.8% | 0 | 12 |
| Hospitalisation | 54 | 2.6% | 3 | 53 |
| Death | 53 | 2.6% | 53 | 9 |
Who Reports BECAPLERMIN Side Effects? Age & Gender Data
Gender: 39.6% female, 60.4% male. Average age: 64.0 years. Most reports from: US. View detailed demographics →
Is BECAPLERMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2006 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 2 |
| 2014 | 23 | 0 | 8 |
| 2015 | 481 | 11 | 95 |
| 2016 | 714 | 23 | 203 |
| 2017 | 327 | 12 | 77 |
| 2018 | 25 | 0 | 2 |
| 2019 | 13 | 0 | 1 |
| 2020 | 6 | 1 | 0 |
| 2021 | 2 | 1 | 0 |
| 2022 | 3 | 0 | 1 |
| 2023 | 4 | 0 | 3 |
| 2025 | 2 | 2 | 0 |
What Is BECAPLERMIN Used For?
| Indication | Reports |
|---|---|
| Wound | 1,012 |
| Diabetic ulcer | 272 |
| Diabetic foot | 187 |
| Skin ulcer | 187 |
| Ulcer | 102 |
| Decubitus ulcer | 33 |
| Blister | 9 |
| Impaired healing | 6 |
BECAPLERMIN vs Alternatives: Which Is Safer?
BECAPLERMIN vs BECLOMETHASONE
BECAPLERMIN vs BECLOMETHASONE DIPROPIONATE
BECAPLERMIN vs BEDAQUILINE
BECAPLERMIN vs BELIMUMAB
BECAPLERMIN vs BEMPEDOIC ACID
BECAPLERMIN vs BENADRYL
BECAPLERMIN vs BENDAMUSTINE
BECAPLERMIN vs BENDROFLUMETHIAZIDE
BECAPLERMIN vs BENRALIZUMAB
BECAPLERMIN vs BENZALKONIUM
Official FDA Label for BECAPLERMIN
Official prescribing information from the FDA-approved drug label.